TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
IMX-110 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pharmacokinetic Profile of T-ChOS™ in Subjects With Advanced Solid Tumors (CHITIN)
- Status
- TERMINATED
- Phase
- PHASE1
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
- Status
- COMPLETED
- Phase
- PHASE1
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
- Status
- RECRUITING
- Phase
- PHASE2
This is a Study to Evaluate the Safety and Tolerability of the Study Drug ABL001, and to Determine the Maximum Tolerated Dose and/or Recommended Phase 2 Study Dose of ABL001
- Status
- COMPLETED
- Phase
- PHASE1
A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of HTI-1090 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A First-in-Human Study of PRL3-ZUMAB
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
M8891 First in Human in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1